|
LAMP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.092600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.768200E-01 |
| Normal-vs-Stage2 |
7.603200E-01 |
| Normal-vs-Stage3 |
4.648600E-01 |
| Normal-vs-Stage4 |
3.091800E-01 |
| Stage1-vs-Stage2 |
6.865400E-01 |
| Stage1-vs-Stage3 |
5.029400E-01 |
| Stage1-vs-Stage4 |
3.353200E-01 |
| Stage2-vs-Stage3 |
4.158000E-01 |
| Stage2-vs-Stage4 |
3.162400E-01 |
| Stage3-vs-Stage4 |
8.750000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.349200E-01 |
| Normal-vs-AfricanAmerican |
3.716600E-03 |
| Normal-vs-Asian |
1.593610E-01 |
| Caucasian-vs-AfricanAmerican |
3.923200E-03 |
| Caucasian-vs-Asian |
5.038600E-01 |
| AfricanAmerican-vs-Asian |
8.356800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.153800E-01 |
| Normal-vs-Female |
6.145800E-02 |
| Male-vs-Female |
5.021600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.566300E-02 |
| Normal-vs-Age(41-60Yrs) |
6.868800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.911800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.906190E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.637630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.765600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.554000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.247800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.287500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.278500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.142800E-01 |
| Normal-vs-Grade 2 |
8.440200E-01 |
| Normal-vs-Grade 3 |
1.543620E-01 |
| Normal-vs-Grade 4 |
5.052400E-01 |
| Grade 1-vs-Grade 2 |
6.327200E-01 |
| Grade 1-vs-Grade 3 |
2.434400E-01 |
| Grade 1-vs-Grade 4 |
3.300200E-01 |
| Grade 2-vs-Grade 3 |
1.152180E-01 |
| Grade 2-vs-Grade 4 |
4.544200E-01 |
| Grade 3-vs-Grade 4 |
9.412600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.750600E-01 |
| Normal-vs-ccB subtype |
8.250000E-01 |
| ccA subtype-vs-ccB subtype |
5.335200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.044400E-01 |
| Normal-vs-N1 |
5.661600E-01 |
| N0-vs-N1 |
5.571600E-01 |
|
|
